Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for…
Medical - Diagnostics & Research
US, Redwood City [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Guardant Health, Inc. (GH) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics & Research Average | - - | - - | - - | 52,479.52 | 1,197.67 | 121.05 | 4,656.95 | 130.38 | 0.00 | 60.8037 | 1.12 | 0.4141 | -0.0079 | 0.00 | -0.07 | 1.5759 | - - | ||
| Maximum | - - | - - | - - | 916,755.00 | 5,796.00 | 1,088.00 | 41,962.00 | 1,448.00 | 0.01 | 1,386.2094 | 8.28 | 0.7332 | 0.2444 | 0.07 | 0.15 | 6.8693 | - - | ||
| Minimum | - - | - - | - - | 29.00 | 19.00 | -110.00 | -3,579.00 | -163.00 | 0.00 | -460.3506 | -1.63 | -0.0242 | -0.5241 | -0.07 | -1.12 | 0.5844 | - - | ||
| Charles River Laboratories International, Inc. CRL | 195.77 | 1.58 0.81% | 575 vs. 718 | 10,010.00 | 1,011.00 | 67.00 | 50.00 | 1,959.00 | 1.4200 | 51.7491 | 0.0000 | 0.3165 | 0.0666 | 0.0185 | 0.0083 | 1.1776 | 51.00 | ||
| Danaher Corporation DHR-PB | 1261.26 | -9.94 -0.78% | 152 vs. 12 | 916,755.00 | 5,796.00 | 1,088.00 | 1,448.00 | 41,962.00 | 1.4700 | 42.4960 | 0.0010 | 0.6016 | 0.1877 | 0.0204 | 0.0130 | 1.3384 | 726.00 | ||
| Illumina, Inc. ILMN | 140.14 | 3.15 2.30% | 2,033 vs. 1,820 | 22,226.00 | 1,076.00 | -126.00 | 41.00 | -145.00 | -0.7900 | -41.8700 | 0.0000 | 0.6199 | -0.1171 | -0.0220 | -0.0125 | 1.1974 | 158.00 | ||
| Thermo Fisher Scientific Inc. TMO | 513.26 | -2.84 -0.55% | 1,611 vs. 1,388 | 196,321.00 | 10,345.00 | 1,328.00 | 904.00 | 48,542.00 | 3.4800 | 41.7964 | 0.0006 | 0.4076 | 0.1284 | 0.0292 | 0.0137 | 1.1918 | 382.00 | ||
| Guardant Health, Inc. GH | 32.65 | 1.67 5.39% | 2,142 vs. 2,119 | 4,034.00 | 168.00 | -114.00 | -37.00 | -2,256.00 | -0.9400 | -5.3587 | 0.0000 | 0.6125 | -0.6824 | -1.6839 | -0.0675 | 5.5171 | 123.00 | ||
| Natera, Inc. NTRA | 167.26 | -2.10 -1.24% | 1,452 vs. 1,188 | 22,081.00 | 367.00 | -67.00 | 6.00 | -2,445.00 | -0.5600 | -41.5349 | 0.0000 | 0.5672 | -0.1838 | -0.0851 | -0.0460 | 3.8297 | 132.00 | ||
| Agilent Technologies, Inc. A | 133.84 | 1.78 1.35% | 1,794 vs. 1,594 | 38,455.00 | 1,573.00 | 308.00 | 230.00 | 1,090.00 | 1.0500 | 32.5915 | 0.0017 | 0.5442 | 0.1958 | 0.0496 | 0.0284 | 1.4913 | 287.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.